---
title: Validation of the ALK-Brain Prognostic Index for patients with ALK-rearranged
  lung cancer and brain metastases
date: '2023-11-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37988952/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231122170715&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The ALK-BPI is a reliable tool for easy prognostic dichotomization
  of TKI-treated ALK+ NSCLC patients with BM in daily clinical practice, without the
  complexity of previous ...'
disable_comments: true
---
CONCLUSIONS: The ALK-BPI is a reliable tool for easy prognostic dichotomization of TKI-treated ALK+ NSCLC patients with BM in daily clinical practice, without the complexity of previous ...